Olmesartan Medoxomil — Class II drug recall D-0077-2027
Ongoing recall by MACLEODS PHARMA USA, INC, reported 2026-11-04, distributed nationwide. Failed Dissolution Specifications.
| Recall number | D-0077-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | MACLEODS PHARMA USA, INC, Princeton, NJ, United States |
| Recall initiated | 2026-10-07 |
| Classified | 2026-10-26 |
| Reported by FDA | 2026-11-04 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 33342-0243, 33342-0243-07, 33342-0243-10, 33342-0244, 33342-0244-07, 33342-0244-10, 33342-0245, 33342-0245-07, 33342-0245-10, 33342-0246, 33342-0246-07, 33342-0246-10, 33342-0247, 33342-0247-07, 33342-0247-10 |
| Expiration dates | 2027-05-31 |
Product
Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for : Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd, Daman, 396210, India
Reason for recall
Failed Dissolution Specifications.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0077-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.